The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.

The BIOFIRE RP2.1 Panel is a frontline test to help clinicians more quickly diagnose URTIs, including COVID-19, influenza, RSV, and many others. The multiplex PCR panel identifies 22 …

The BioFire Respiratory 2.1 Panel (RP2.1) is a multiplex polymerase chain reaction (PCR) test that identifies nucleic acids from 23 difer-ent bacteria and viruses that commonly cause upper …

This article provides a comprehensive, clinician-friendly explanation of the BioFire Test, including how it works, available panels, clinical indications, advantages, limitations, and its growing role …

The BIOFIRE System is the new standard for syndromic infectious disease diagnostics. Simple, fast, and comprehensive, the BIOFIRE System delivers accurate results in about one hour.

Oct 16, 2025 · The BioFire® Respiratory Panel is an incredible diagnostic tool that provides rapid, actionable information for sick patients. However, its utility in the routine pre-operative …

Designed with the syndromic approach in mind, each panel can detect a broad grouping of probable pathogenic causes in a single, rapid test. The BioFire Panels test for viruses, …

This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the BioFire COVID-19 Test.

The SPOTFIRE R/ST Panels bring PCR diagnostics closer to patients, testing for a broad grouping of probable respiratory and sore throat pathogens into one rapid test. The panels’ …

Dec 22, 2020 · The BioFire RP2.1 is a molecular (PCR) test authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. …